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Higher sleep fragmentation predicts a lower magnitude
of weight loss in overweight and obese women participating
in a weight-loss intervention
R Sawamoto1, T Nozaki1, T Furukawa1, T Tanahashi1, C Morita1, T Hata1, G Komaki2 and N Sudo1
BACKGROUND: Sleep has been identified as having an influence on the success of weight-loss interventions; however, knowledge
of the mechanisms and the extent to which sleep disturbances affect the magnitude of weight reduction is inconclusive.
OBJECTIVE: To determine if sleep duration and quality can predict the magnitude of weight reduction in a weight-loss intervention
program for overweight and obese women.
METHODS: Ninety overweight and obese women aged 25–65 years completed the 7-month weight-loss phase of our weight-loss
intervention. Sleep duration and quality were evaluated before the intervention by the Pittsburg Sleep Quality Index (PSQI), a self-
report questionnaire, and by actigraphy. Serum levels of ghrelin, leptin, cortisol and insulin also were measured at baseline. Insulin
resistance was measured by the homeostasis model assessment of insulin resistance (HOMA-IR).
RESULTS: The mean reduction rate of body mass index (BMI) after the intervention was 13.6%. Multiple linear regression revealed
that the number of wake episodes (WEs) per night had a significant relationship with the reduction of BMI even after adjusting for
other clinical variables (β=− 0.341, P= 0.001). The participants with five or more WEs per night (high-WE group) had a significantly
lower reduction in BMI compared with those with fewer than five (normal-WE group), after adjusting for confounding variables. In
contrast, the PSQI-assessed parameters, reflecting the subjective assessments of sleep quality and duration, failed to detect an
association with the reduction in BMI. Baseline HOMA-IR was significantly higher in the high-WE group than in the normal-WE
group after adjusting for confounding variables.
CONCLUSIONS: Higher sleep fragmentation, as manifested by the increased number of WEs, predicts a lower magnitude of weight
reduction in persons participating in weight-loss programs.
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INTRODUCTION
Obesity is a major healthcare problem that contributes to a
number of diseases, including cardiovascular disease and diabetes
mellitus, and it has enormous economic implications for society.1
The prevalence of obesity has increased markedly throughout the
world in recent decades.2
The development and persistence of obesity are known to be
influenced by a variety of environmental factors, such as excessive
daily food intake and physical inactivity.2 Accumulating evidence
also supports the hypothesis that sleep disturbance is an
important contributing factor to obesity. Numerous epidemio-
logical studies conducted in different geographical regions have
investigated the association between sleep and obesity among
different populations.3–7 The majority of these studies have found
a relationship between short sleep duration and an increased risk
of obesity.6 For example, a recent meta-analysis of 17 studies of
603 519 adults reported a pooled obesity odds ratio of 1.55 in
those who had fewer than 5 hours of sleep, and a decrease in
body mass index (BMI) by 0.35 kgm− 2 for each additional hour of
sleep.7
In addition to sleep duration, the quality of sleep has been
suggested as an influential variable in the relationship between
sleep and obesity.8,9 In the multivariate analysis of the
Cardiovascular Health Epidemiology Study,10 in which sleep
duration and quality were assessed by the Pittsburg Sleep Quality
Index (PSQI), the effect of sleep duration on the risk of obesity was
rather modest. However, a significant association between poorer
sleep quality and an increased BMI was found in women. The
importance of sleep quality was reported in the Rotterdam Study,9
which found that BMI increased by 0.59 kgm− 2 per s.d. of sleep
fragmentation, as measured by actigraphy. This study also found
that both short sleepers (o5 h or–6 h per night) and long sleepers
(48 h) were more likely to be obese in comparison with
participants who slept between 7 and 8 hours, as measured by
actigraphy. However, the association between short sleep and
obesity was no longer significant after adjusting for actigraphy-
assessed sleep fragmentation. Furthermore, self-reports of habi-
tual sleep duration were not associated with BMI or obesity, which
suggests the importance of conducting objective assessments in
sleep studies.
It is clear that quantitative and qualitative aspects of sleep have
profound effects on weight regulation. However, knowledge of
how, and to what extent sleep disturbances affect weight
regulation is inconclusive. There are a considerable number of
discrepancies in study results based on subjective and objective
parameters. To date, there are no studies that have reported the
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effects of objective sleep parameters on weight reduction in a
weight-loss intervention program for obese people. If the effect of
sleep on weight regulation can be measured before treatment, it
should provide a useful tool for weight-loss intervention.
The aim of this study was to determine if objective and
subjective sleep-related parameters at baseline predict the
magnitude of weight loss in a sample of overweight and obese
women, following a weight-loss intervention program.
MATERIALS AND METHODS
Study design
This investigation was part of a randomized-controlled study consisting of
a two-phase trial that examined two strategies for maintaining weight loss.
The weight-loss phase provided an intensive program of cognitive
behavioral therapy for weight loss that lasted 7 months. Participants
who lost at least 5% of their initial body weight during the weight-loss
phase were eligible for the 3-month program provided in the weight
maintenance phase. In this phase, the participants were randomized to
one of two weight-loss maintenance interventions, with follow-up through
34 months after their initial entry into the study. All of the participants
provided informed consent, and the Institutional Review Boards of Kyushu
University Hospital approved the study protocol.
Eligibility
All of the participants were women aged 20–65 years, with a BMI of
25 kgm− 2 or higher. They were able to understand and complete self-
report questionnaires written in Japanese without assistance, and had no
physical impairment that would preclude simple exercise. Those who met
the following criteria were excluded from the study: weight loss of 45 kg
during the previous 6 months, current diagnosis of bulimia nervosa, past
history of anorexia nervosa, current pregnancy or breast feeding, planning
to become pregnant within the next 24 months, taking any form of
medication that would affect body weight, suffering from any health
disorder affecting body weight, receiving continuous positive airway
pressure therapy for obstructive sleep apnea, receiving a current treatment
for psychiatric disorders or planning to move within the next 10 months.
Recruitment and entry
We recruited participants through the local newspaper, the university
website, posters in the university hospital or hospitals near the university
and a television program. Those who were interested and potentially
eligible were scheduled for an information session to learn more about the
study. At the information session, the principal investigator provided the
details of the study and answered questions from the participants. Those
who met the eligibility criteria were enrolled in the study. After informed
consent was obtained, we collected demographic, lifestyle and health
history data on the participants.
Weight-loss intervention
Cooper et al.11 originally developed the cognitive behavioral therapy
program for obese individuals. We modified it for use in a group-therapy
program12,13 that included the clinical guidelines on obesity of the US
National Institutes of Health,14 Look AHEAD (Action for Health in
Diabetes)15and the Diabetes Prevention Program as a framework.16 Our
treatment program was conducted in small groups of ~ 10 individuals. It
consisted of 35 group sessions, each of them lasing 90min, and 5
individual sessions over the 44-week period. The sessions were conducted
once a week for the first consecutive 34 sessions, and the remaining
sessions were held once every 2 weeks.
Two doctors and two certified nutritionists were involved as the
healthcare providers in the participants’ treatment. All participants were
instructed to keep a daily food diary to track their consumption of all food
and drinks, wear a pedometer and record their daily number of steps. They
also were advised to reduce their dietary intake by 500 calories per day
from their caloric intake at the beginning of their therapy. The nutritionists
checked the nutritional balance of the participants’ diets by examining
their recordings of their food intake, and advised participants about the
importance of eating vegetables and reducing the consumption of fat
foods and sweets. The participants were advised to increase their level of
physical exercise to a moderate intensity, such as walking (8000–10 000
steps per day). Furthermore, a series of stress-management sessions also
was included in the program.
Anthropometric and body composition measurements
Our staff measured the participants’ height, body weight, waist
circumference and hip circumference. The participants were asked to
weigh themselves once a week, on the morning of their session.
The percent of body fat was measured at baseline and at the end of the
weight loss phase using the Dual Energy X-ray Absorptiometry system
(QDA4500A: HOLOGIC, Bedford, MA, USA).
Dietary intake and physical activity
From the diet and exercise logs that the participants recorded, we
calculated the mean food calories and the number of steps that the
participants took during the weight-loss phase.
Depression and anxiety
Depression was evaluated using the Japanese version of the Center for
Epidemiologic Studies-Depression Scale (CES-D). The CES-D is a 20-item,
self-report questionnaire. The scores range from 0–60, with a higher score
indicating the presence of depressive symptoms.17 Anxiety was evaluated
using the Japanese version of the State-Trait Anxiety Inventory (STAI). The
STAI is a self-report questionnaire consisting of two scales, the state and
trait forms (STAI-1 assesses state anxiety and STAI-2 assesses trait-anxiety).
Each scale consists of 20 items that indicate the presence or absence of
anxiety symptoms.18
Sleep parameters
To obtain objective sleep parameters, we used actigraphy (Micro-mini RC,
Ambulatory Monitoring, Inc., Ardsley, NY, USA). The participants were
instructed to wear an actigraph continuously over a period of 5–7
consecutive days and nights, on the non-dominant wrist upon their entry
into the program. It was set for 1-min epochs, in zero-crossing mode. The
data retrieved from the actigraph were downloaded to a personal
computer using the automatic actigraphy interface unit. These data were
analyzed and scored using Action W-2 version 2.4.20 software (Ambulatory
Monitoring, Inc.), to calculate sleep quality parameters, including sleep
latency (number of minutes before the start of the first 20-min block of
sleep), sleep minutes (total minutes scored as sleep), sleep efficiency
(100× sleep minutes/duration from first 20-min block of sleep to the last
one), wake episodes (WEs) (the number of continuous blocks of one-
minute wake epochs), wake after sleep onset (total wake minutes during
nocturnal sleep), mean WEs (mean duration of WEs), long WEs (the number
of blocks of WEs lasting 5min or more) and the longest WE (duration of the
longest WE). As the average number of WE was reported to be 4.0 times
per night in normal sleepers,19 we used 5 times per night as a reasonable
cutoff point for the high-WE group. All actigraphy-based measures were
averaged over the total number of nights.
Subjective sleep parameters also were evaluated by the Pittsburgh Sleep
Quality Index (PSQI), a self-rated questionnaire that assesses sleep quality
and disturbances over the preceding 1-month interval.20 The instrument
consists of 19 items, plus a five-item rating provided by a bed partner who
is not included in scoring. A total PSQI score is highly sensitive and specific
in distinguishing good from poor sleepers,20 and has been validated in a
number of populations.21 In the current study, sleep quality (total PSQI
score), sleep duration and Question 10 b, from the apnea subscale, were
used for statistical analyses.
Measurement of hormonal markers
Blood samples were drawn from a vein in the antecubital fossa in the
morning (10:00–12:00 am). The separated serum samples were stored at
−80 °C until they were analyzed. Serum hormone levels were measured
using commercially available kits. Ghrelin, insulin and growth hormone were
analyzed by enzyme-linked immunosorbent assay: (a) active-ghrelin,
(Molecular Devices, Tokyo, Japan; intra-assay coefficient of variation (CV)
2.13% and interassay CV 8.10%); (b) insulin, (TOSHO, Tokyo, Japan; intra-assay
CV 2.6% and interassay CV 2.8%); (c) growth hormone, (THOSHO; intra-assay
CV 2.6% and interassay CV 2.8%). Serum leptin, insulin-like growth factor-1
and cortisol levels were analyzed by radioimmunoassay: (a) serum leptin,
(Hitachi Aloka Medical, Ltd., Tokyo, Japan; intra-assay CV 5.3% and interassay
CV 8.1% ); immunoradiometric: (b) insulin-like growth factor-1, (Hitachi Aloka
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Medical, Ltd; intra-assay CV 1.1% and interassay CV 2.2%) and electro-
chemiluminescent: (c) cortisol, (Roche Diagnostics, Tokyo, Japan; intra-assay
CV 1.68% and interassay CV 2.12%). Insulin resistance was calculated
according to the following formula: homeostasis model assessment-insulin
resistance= fasting insulin (μUml−1) × fasting glucose (mg dl−1)/405.
Statistical analysis
The changes in clinical data between baseline measures and those taken at
the end of the weight-loss phase were calculated using the paired-t test.
Pearson's correlation coefficient was performed to examine the associa-
tions among the reduction in BMI, demographic, clinical, psychological and
sleep-related variables. Simple and multiple regression analyses were used
to clarify which variable at baseline was a predictor of the reduction in BMI.
Student's t-test and analysis of covariance were used to analyze the
reduction in BMI and hormonal markers between the participants with five
or more WEs per night and those below five. Dummy codes were applied
to marital status (single = 0, marriage= 1), working status (working= 0, not
working= 1) and smoking status (nonsmoker = 0, smoker = 1), in Pearson's
correlation test, simple and multiple regression analyses and analysis of
covariance. All of the continuous variables are expressed as the means ± s.
d. All statistical analyses were performed with the SPSS software package
(version 19.0 J for Windows). A value of Po0.05 was considered
significant.
RESULTS
Recruitment and baseline characteristics
A total of 230 women were screened for inclusion in the weight-
loss program and 119 were enrolled (Figure 1). In total, 90 of 119
participants (75.6%) completed the weight-loss phase of the
program. Their baseline characteristics are presented in Table 1.
The participants’ mean age and BMIs were 47.9 (25–65) years and
31.1 (25.1–46.0) kg m− 2, respectively.
Kinetics of body weight
Changes in the clinical data between the baseline measures and
those taken at the end of the weight-loss phase are presented in
Table 1. The mean number of kg lost and the percentage of BMI
reduced were 10.3 ± 4.8 kg and 13.6 ± 0.1%, respectively. All
participants who completed the weight-loss phase lost 45% of
their initial body weight. In total, 65 of 90 (72%) participants lost
10% or more of their initial body weight.
Relationship between the reduction in BMI and the objective sleep
parameters
The baseline averages of the participants’ sleep parameters as
measured by actigraphy were as follows: sleep minutes = 332 min,
sleep efficiency = 93%, and WEs = 5.72 per night (Supplementary
Table 1). A significant correlation was found between the
reduction in BMI and sleep parameters (baseline sleep efficiency
and WEs) (Table 2, Supplementary Figure 1). Sleep efficiency and
WEs also correlated significantly with the reduction in body fat
ratio (sleep efficiency: r= 0.258, P= 0.015 and WEs: r= 0.239,
P= 0.03). However, the correlation between sleep efficiency and
WEs with the reduced BMI was stronger than with the reduced
body fat ratio; therefore, BMI was chosen as a dependent variable
in the regression analysis.
Simple regression analysis revealed that the reduction in BMI
was associated with smoking status, the total calorie intake
per day during treatment, and the number of WEs at baseline
(Table 3). However, age, BMI, marital and working status, the CES-
D, baseline STAI scores and the number of steps walked per day
during treatment, did not reveal a significant correlation with the
reduction in BMI. Because WEs had a high correlation with sleep
efficiency and a higher correlation with BMI reduction than sleep
efficiency (Table 2), only the number of WEs was entered as the
independent variable in the multiple regression analysis to avoid
multicollinearity, as shown in Table 3. The number of WEs
remained significant even after adjusting for age, baseline BMI,
smoking status, CES-D score and the total calorie intake per day
during treatment. Of all the independent variables, the number of
WEs also was the strongest predictor of BMI reduction (β=− 0.341,
P= 0.002). As Figure 2 illustrates, the reduction in BMI was
significantly different between the participants with fewer than
five WEs per night (the normal-WE group) and those with five or
more WEs per night (the high-WE group). This difference was
found after adjusting for age, baseline BMI, smoking status, CES-D
score, average daily caloric intake and average number of daily
steps during treatment, using analysis of covariance (F= 6.289,
P= 0.014).
Among the subjective measures of sleep assessment, sleep
duration as measured by the PSQI, exhibited a linear relationship
with sleep minutes, as measured by actigraphy (r = 0.229,
P= 0.0127). The PSQI total score was not associated with any of
Figure 1. Flow diagram of participants. Of 230 persons who
contacted us by telephone or e-mail to participate in the study, 81
were excluded because of not meeting inclusion criteria (n= 45),
schedule conflicts (n= 20) or not being interested in the study
(n= 16). Of the remaining 149 persons, 14 did not appear in the
group information session because of unknown reasons, and 6
refused to participate in the study after the group information
session. Of the remaining 129 persons who attended the screening
visit, 10 were excluded because of not meeting the inclusion criteria.
The remaining 119 participants agreed to participate in the weight
loss program. After the program was initiated, 29 persons dropped
out because of their unwillingness to continue with the program
(n= 14), schedule conflicts (n= 6), family problems (n= 5) and health
problems unrelated to the program (n= 4). Complete sets of data
were collected from 90 of the initial 119 participants.
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the acitigraphy-measured sleep parameters. The apnea subscale
of the PSQI correlated only with wake after sleep onset, as
assessed by actigraphy (r= 0.250, P= 0.0326). However, none of
the three PSQI parameters (sleep duration, sleep quality and
apnea) were correlated with BMI reduction (sleep duration:
r = − 0.178, P= 0.186; sleep quality: r = − 0.0127, P= 0.905; and
apnea: r=− 0.0363, P= 0.760).
Relationship between hormonal markers and WEs
Analysis of covariance on the baseline hormonal markers showed
that homeostasis model assessment of insulin resistance and
cortisol levels were significantly different between the normal-
and the high-WE groups. None of the other baseline hormonal
markers differed between the two groups (Table 4).
DISCUSSION
In the current study, highly fragmented sleep, as revealed by the
increased number of WEs on an actigraph, predicted a lower
magnitude of weight loss in a sample of overweight and obese
women participating in a weight-loss intervention. These results
support the current view that sleep quality is an important factor
contributing to weight reduction and indicate the importance of
using objective sleep measures in the assessment of sleep quality.
Several clinical studies with longitudinal designs have found
that baseline parameters of sleep can predict the efficacy of a
long-term weight-loss intervention program. For example, sleep
duration was reported to predict success in an intensive 6-month
behavioral weight-loss program in 472 obese adult participants.22
Thomson et al.23 examined the baseline measures of sleep
duration and quality of 245 overweight or obese women who
participated in a 24-month commercial multifaceted weight-loss
program, and thereafter, evaluated how sleep parameters
assessed by the PSQI affected weight reduction. They found that
in addition to the participants who reported sleeping ⩽ 7 h per
night, those with poor subjective sleep quality were significantly
less likely to achieve successful weight loss. These findings
suggest that sleep quality and sleep duration can predict the
efficacy of long-term weight-loss interventions. However, because
some of the sleep parameters were measured by subjective
instruments (that is, self-report questionnaires), these sleep
measures may be biased by the participants’ own perceptions.
The current study used actigraphy to assess the effects of sleep
quality on weight loss, and the results suggested the importance
of using objective sleep measures in addition to subjective ones in
the assessment of sleep quality.
In contrast to the studies mentioned above, our findings
revealed that sleep duration at baseline was not associated with
the degree of weight loss, as expected. The reason for this
discrepancy is unclear so far. However, it might be related to a
difference in the methods used to assess sleep parameters,
because the other studies assessed sleep duration and quality
using only self-report questionnaires.22,23 Nevertheless, we cannot
rule out the importance of sleep duration when considering the
risk or prevention of vulnerability to obesity. Further studies are
needed to clarify whether short sleep duration per se or short
sleep due to frequent interruptions causes an increased risk of
obesity.
In this study, WEs, which were strongly related to sleep quality,
significantly contributed to the magnitude of weight loss, even
after adjusting for confounding factors, such as the number of
steps walked and total calorie intake, which are known to be key
factors in weight-loss success. The precise mechanism, which
explains the effect of fragmented sleep on weight loss, remains to
be elucidated; however, several possible pathways or mechanisms
have been suggested. Stamatakiset al.24 elicited fragmented sleep
across all of the sleep stages in 11 healthy volunteers for two
nights in a laboratory setting, using auditory and mechanical
stimuli. They showed that sleep fragmentation decreased both
insulin sensitivity and glucose effectiveness. Similarly, in a 24 h
randomized crossover study, it was reported that a single night of
fragmented sleep resulted in reduced REM sleep, a shift in insulin
concentration and a decrease in glucagon-like peptide-1
concentrations.25 These findings are consistent with the results
Table 1. Sociodemographic, clinical and psychological characteristics
of participants
Characteristic At baseline At the end of
weight-loss
phase
P-value
Sociodemographics
Age (years) 47.9± 12
Marital status—single, n (%) 32 (35.6)
Working status—working, n (%) 53 (58.9)
Smoking status—smoker, n (%) 13 (14.4)
Clinical
BMI (kgm−2) 31.1± 4.7 26.9± 4.6 o0.001
Body weight (kg) 77.6± 12 66.1± 12 o0.001
Waist (cm) 98.6± 11 86.9± 12 o0.001
Hip (cm) 107.2± 9.9 97.1± 9.7 o0.001
Total body fat (%) 37.6± 3.8 32.9± 5.1 o0.001
Steps per day 6424± 2730 8020± 3157 o0.001
Calorie intake (kcal per day) 1786± 354 1176± 195 o0.001
Psychological
Depression (CES-D) 11.4± 6.8
Anxiety (STAI-state) 41.0± 9.5
Anxiety (STAI-trait) 44.2± 12
Abbreviations: CES-D, Center for Epidemiologic Studies-Depression Scale;
STAI, State-Trait Anxiety Inventory. Values are expressed as the means
± s.d., or n(%) of 90 participants.
Table 2. Correlations among the reduction rate of BMI and actigraphic sleep parameters
(1) (2) (3) (4) (5) (6) (7) (8) (9)
1) Reduction rate of BMI 1
2) Sleep latency − 0.198 1
3) Sleep minutes 0.066 − 0.105 1
4) Sleep efficiency 0.271** − 0.208* 0.377** 1
5) Wake after sleep onset − 0.205 0.176 − 0.272** − 0.951** 1
6) Wake episodes − 0.350** 0.195 0.016 − 0.720** 0.698** 1
7) Mean wake episode − 0.123 0.243* − 0.222* − 0.132 0.132 − 0.003 1
8) Long wake Episodes 0.126 0.113 − 0.068 − 0.483** 0.513** 0.372* 0.087 1
9) Longest wake episode − 0.228 0.554** − 0.237* − 0.377** 0.362** 0.189 0.858** 0.219* 1
Abbreviation: BMI, body mass index. Values shown are correlation coefficient (r). *Po0.05, **Po0.01.
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of the current study showing that homeostasis model assessment
of insulin resistance was significantly higher in the high-WE group
compared with the normal-WE group, suggesting that fragmented
sleep may attenuate the magnitude of weight loss by inducing
insulin resistance in the hosts.25
In the current study, serum cortisol levels were lower in the
high-WE group than in the normal group, indicating that sleep
fragmentation may cause dysregulation of the hypothalamic-
pituitary-adrenal axis. Previous studies have found that nocturnal
awakenings are associated with an evening pulsatile release of
cortisol, which is followed by a temporary inhibition of cortisol
secretion the following morning.26,27 These findings suggest that
wakefulness may increase negative feedback sensitivity of the
hypothalamic-pituitary-adrenal axis.28 Karaca et al.29 suggested
that the enhanced sensitivity of the hypothalamic-pituitary-
adrenal axis to the negative feedback effect of cortisol may lead
to decreased cortisol levels in the morning. Although we did not
perform real-time monitoring of serum cortisol levels in this study,
the decreased level of cortisol in the morning in the high-WE
group might accompanied the elevated levels of evening cortisol,
similar to the findings of previous studies.26,27 Furthermore,
increased cortisol levels in the evening have been reported to
be associated with decreased insulin sensitivity the following
morning.30,31 This may lead to the development of insulin
resistance over time.32 Taken together, increased levels of
nocturnal cortisol induced by sleep fragmentation may explain
the increased insulin resistance in the high-WE group and result in
difficulties with weight reduction in diet interventions.
We failed to find associations between appetite-related
hormones, such as leptin and ghrelin, and WEs, although a
previous study suggested a possible relationship between plasma
leptin levels and fragmented sleep. In an animal experiment,
fragmented sleep induced an increase in weight gain and
changed plasma leptin levels, implicating the possible involve-
ment of plasma leptin in weight gain.33 Further studies are needed
to clarify the role of appetite-related hormones in the relationship
between sleep disturbances and weight regulation in humans.
It should be noted that the present study has several limitations.
First, our sample size is relatively small and we cannot apply our
results to obese men because all of the participants were women.
Second, we cannot exclude the possibility that variables other
than those we examined, such as sleep apnea and environmental
noise, may have affected our results. Third, the dropout rate
(24.3%) of the participants was relatively high, which might have
contributed to a selection bias in the results. Finally, although the
association between fragmented sleep and weight loss was an
important observation, further intervention studies should be
conducted to demonstrate the causality of this observation.
In summary, baseline measures of sleep fragmentation may
predict the magnitude of weight reduction in weight-loss interven-
tions. Clearly, further studies are needed to clarify whether or not
improving sleep quality may actually increase the body’s efficiency
in weight reduction. Such studies could facilitate the development
of novel strategies to tackle the pervasive problem of obesity.
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Table 3. Simple and multiple regression analyses among BMI
reduction rate and other clinical variables
Independent variables Simple
regression
Multiple
regressiona
β P β P
Age 0.123 NS 0.066 NS
Baseline BMI − 0.078 NS − 0.016 NS
Marital status 0.063 NS NI NI
Working status − 0.014 NS NI NI
Smoking status 0.236 0.025 0.216 0.033
CES-D − 0.200 0.059 − 0.167 NS
STAI-state − 0.171 NS NI NI
STAI-trait − 0.134 NS NI NI
The number of walking steps
per day during treatment
0.048 NI NI NI
Total calorie intake per day during
treatment
− 0.229 0.030 − 0.261 0.01
The number of wake episodes per
night at baseline
− 0.350 0.001 − 0.341 0.001
Abbreviations: BMI, body mass index; CES-D, Center for Epidemiologic
Studies-Depression Scale; β, standard regression coefficients; NI, not insert;
NS, not significant; STAI, State-Trait Anxiety Inventory. aAdjusted R2= 0.273,
F= 5.187, P= 0.002.
Figure 2. Differences in BMI reduction between the normal- and
high-WE groups. All data are expressed as the mean± s.d. The mean
reduction of BMI in the normal- and high-WE group was 15.4% and
11.7%, respectively. The difference was significant after adjusting for
age, baseline BMI, smoking status, CES-D scores, average daily
caloric intake and average daily number of steps during treatment
using ANCOVA (F= 6.289, *P= 0.014).
Table 4. Baseline hormonal markers in the normal and the high-WE
groups
Hormone WEsa t-test ANCOVAb
Normal
(WEso5)
High
(WEs⩾ 5)
P F P
Ghrelin (fmol ml− 1) 13.4± 7.9 12.1± 8.1 NS − −
Leptin (ngml− 1) 24.2± 12 26.8± 12 NS − −
IGF (ngml− 1) 150± 38 139± 44 NS − −
GH (ngml− 1) 0.57± 0.69 0.53± 0.76 NS − −
Insulin (μUml− 1) 9.20± 5.3 13.5± 0.93 0.009 2.007 NS
HOMA-IR 2.36± 1.6 3.76± 2.80 0.005 4.458 0.038
Cortisol (μUml− 1) 8.79± 3.1 7.56±3.3 NS 5.515 0.021
Abbreviations: NS, not significant; WEs, wake episodes. aAll values are
expressed as the mean± s.d. of 90 participants. bAdjusted by age, baseline
BMI, smoking status and CES-D.
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